51 employees
RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas.
2021
$140M
from 1 investors over 1 rounds
RVAC Medicines raised $140M on April 26, 2022
Investors: EDBI Pte Ltd